Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Stephan

Showing results (21-30 of 222) with videos related to

Pageof 23
Sort By:
Clinical Chemistry|February 26, 2003
Comparison of eight computer programs for receiver-operating characteristic analysisCarsten Stephan, Sebastian Wesseling, Tania Schink, et al.
European Journal of Cancer (Oxford, England : 1990)|August 11, 2007
PSA and other tissue kallikreins for prostate cancer detectionCarsten Stephan, Klaus Jung, Michael Lein, et al.
Clinical Chemistry|September 17, 2011
Avoiding pitfalls in applying prediction models, as illustrated by the example of prostate cancer diagnosisHenning Cammann, Klaus Jung, Hellmuth-A Meyer, et al.
Clinical Chemistry|June 3, 2011
MicroRNAs as regulators of signal transduction in urological tumorsAnnika Fendler, Carsten Stephan, George M Yousef, et al.
European Urology|November 2, 2005
Re: Roddam AW, Duffy MJ, Hamdy FC, et al. Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA Level of 2-10 ng/ml: systematic review and meta-analysis. Eur Urol 2005;48:386-99Carsten Stephan, Dietmar Schnorr, Stefan A Loening, et al.
Journal of Proteome Research|June 27, 2008
Proteomic analysis of conditioned media from the PC3, LNCaP, and 22Rv1 prostate cancer cell lines: discovery and validation of candidate prostate cancer biomarkersGirish Sardana, Klaus Jung, Carsten Stephan, et al.
Journal of Biomedicine & Biotechnology|May 10, 2008
Classification models for early detection of prostate cancerJoerg D Wichard, Henning Cammann, Carsten Stephan, et al.
Oncology Reports|March 15, 2011
Importance of brain‑type fatty acid binding protein for cell-biological processes in human renal carcinoma cellsAngelika Tölle, Hans Krause, Kurt Miller, et al.
The Prostate|October 26, 2011
RECK overexpression decreases invasive potential in prostate cancer cellsAnja Rabien, Bettina Ergün, Andreas Erbersdobler, et al.
EJIFCC|September 30, 2016
Prostate-Specific Antigen (PSA) Screening and New Biomarkers for Prostate Cancer (PCa)Carsten Stephan, Harry Rittenhouse, Xinhai Hu, et al.
Pageof 23

Showing results (21-30 of 222) with videos related to

Sort By:
Pageof 23
Clinical Chemistry|February 26, 2003
Comparison of eight computer programs for receiver-operating characteristic analysisCarsten Stephan, Sebastian Wesseling, Tania Schink, et al.
European Journal of Cancer (Oxford, England : 1990)|August 11, 2007
PSA and other tissue kallikreins for prostate cancer detectionCarsten Stephan, Klaus Jung, Michael Lein, et al.
Clinical Chemistry|September 17, 2011
Avoiding pitfalls in applying prediction models, as illustrated by the example of prostate cancer diagnosisHenning Cammann, Klaus Jung, Hellmuth-A Meyer, et al.
Clinical Chemistry|June 3, 2011
MicroRNAs as regulators of signal transduction in urological tumorsAnnika Fendler, Carsten Stephan, George M Yousef, et al.
European Urology|November 2, 2005
Re: Roddam AW, Duffy MJ, Hamdy FC, et al. Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA Level of 2-10 ng/ml: systematic review and meta-analysis. Eur Urol 2005;48:386-99Carsten Stephan, Dietmar Schnorr, Stefan A Loening, et al.
Journal of Proteome Research|June 27, 2008
Proteomic analysis of conditioned media from the PC3, LNCaP, and 22Rv1 prostate cancer cell lines: discovery and validation of candidate prostate cancer biomarkersGirish Sardana, Klaus Jung, Carsten Stephan, et al.
Journal of Biomedicine & Biotechnology|May 10, 2008
Classification models for early detection of prostate cancerJoerg D Wichard, Henning Cammann, Carsten Stephan, et al.
Oncology Reports|March 15, 2011
Importance of brain‑type fatty acid binding protein for cell-biological processes in human renal carcinoma cellsAngelika Tölle, Hans Krause, Kurt Miller, et al.
The Prostate|October 26, 2011
RECK overexpression decreases invasive potential in prostate cancer cellsAnja Rabien, Bettina Ergün, Andreas Erbersdobler, et al.
EJIFCC|September 30, 2016
Prostate-Specific Antigen (PSA) Screening and New Biomarkers for Prostate Cancer (PCa)Carsten Stephan, Harry Rittenhouse, Xinhai Hu, et al.
Pageof 23